Catalyst Pharmaceuticals Inc 2023 Sustainability Report
Company: Catalyst Pharmaceuticals Inc
Sector: Manufacturing
Country: United States
Year: 2023
Type: Sustainability Report
Pages: 42
The report describes Catalyst's 2023 transformation through acquisitions of FYCOMPA and AGAMREE, geographic expansion, and revenue growth. It highlights patient access through Catalyst Pathways, including expansion to AGAMREE patients, and reports 164 total employees at year-end. ESG oversight is assigned to the Board, supported by a Corporate Responsibility Steering Committee. The performance tables report 2.1 Metric tons of waste generated and 28.6% female Board representation in 2023.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.